Ipca Laboratories Limited IPCALAB.NS Stock
Ipca Laboratories Limited Price Chart
Ipca Laboratories Limited IPCALAB.NS Financial and Trading Overview
| Ipca Laboratories Limited stock price | 1318.25 INR |
| Previous Close | 720.65 INR |
| Open | 722 INR |
| Bid | 735.85 INR x 0 |
| Ask | 736.05 INR x 0 |
| Day's Range | 720.25 - 737.5 INR |
| 52 Week Range | 669.8 - 1034.3 INR |
| Volume | 376.33K INR |
| Avg. Volume | 797.89K INR |
| Market Cap | 186.65B INR |
| Beta (5Y Monthly) | 0.134931 |
| PE Ratio (TTM) | 38.66001 |
| EPS (TTM) | 22.23 INR |
| Forward Dividend & Yield | 4 (0.55%) |
| Ex-Dividend Date | November 22, 2022 |
| 1y Target Est | 856.76 INR |
IPCALAB.NS Valuation Measures
| Enterprise Value | 175.41B INR |
| Trailing P/E | 38.66001 |
| Forward P/E | 16.873854 |
| PEG Ratio (5 yr expected) | 0.47 |
| Price/Sales (ttm) | 2.9891171 |
| Price/Book (mrq) | 3.1908436 |
| Enterprise Value/Revenue | 2.809 |
| Enterprise Value/EBITDA | 18.927 |
Trading Information
Ipca Laboratories Limited Stock Price History
| Beta (5Y Monthly) | 0.134931 |
| 52-Week Change | -16.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1034.3 INR |
| 52 Week Low | 669.8 INR |
| 50-Day Moving Average | 734.98 INR |
| 200-Day Moving Average | 828.16 INR |
IPCALAB.NS Share Statistics
| Avg. Volume (3 month) | 797.89K INR |
| Avg. Daily Volume (10-Days) | 999.96K INR |
| Shares Outstanding | 253.7M |
| Float | 130.31M |
| Short Ratio | N/A |
| % Held by Insiders | 46.66% |
| % Held by Institutions | 40.68% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 37.00% |
| Payout Ratio | 0.21530001 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 7.54% |
| Operating Margin (ttm) | 10.65% |
| Gross Margin | 63.06% |
| EBITDA Margin | 14.84% |
Management Effectiveness
| Return on Assets (ttm) | 5.11% |
| Return on Equity (ttm) | 8.34% |
Income Statement
| Revenue (ttm) | 62.44B INR |
| Revenue Per Share (ttm) | 246.16 INR |
| Quarterly Revenue Growth (yoy) | 17.19% |
| Gross Profit (ttm) | 40.63B INR |
| EBITDA | 9.27B INR |
| Net Income Avi to Common (ttm) | 4.71B INR |
| Diluted EPS (ttm) | 19.03 |
| Quarterly Earnings Growth (yoy) | -41.19% |
Balance Sheet
| Total Cash (mrq) | 21.77B INR |
| Total Cash Per Share (mrq) | 85.9 INR |
| Total Debt (mrq) | 14.81B INR |
| Total Debt/Equity (mrq) | 25.04 INR |
| Current Ratio (mrq) | 2.874 |
| Book Value Per Share (mrq) | 230.566 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 8.06B INR |
| Levered Free Cash Flow (ttm) | 1.67B INR |
Profile of Ipca Laboratories Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | 125, Kandivli Industrial Estate |
| ZIP | 400067 |
| Phone | 91 22 6210 5000 |
| Website | https://www.ipca.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
Q&A For Ipca Laboratories Limited Stock
What is a current IPCALAB.NS stock price?
Ipca Laboratories Limited IPCALAB.NS stock price today per share is 1318.25 INR.
How to purchase Ipca Laboratories Limited stock?
You can buy IPCALAB.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ipca Laboratories Limited?
The stock symbol or ticker of Ipca Laboratories Limited is IPCALAB.NS.
Which industry does the Ipca Laboratories Limited company belong to?
The Ipca Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ipca Laboratories Limited have in circulation?
The max supply of Ipca Laboratories Limited shares is 253.82M.
What is Ipca Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Ipca Laboratories Limited PE Ratio is 59.30049500 now.
What was Ipca Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Ipca Laboratories Limited EPS is 22.23 INR over the trailing 12 months.
Which sector does the Ipca Laboratories Limited company belong to?
The Ipca Laboratories Limited sector is Healthcare.